Precision Medicine

The last podcast in this series looks at current opportunities presented by advancements in Precision Medicine. How are healthcare organizations and patients learning to leverage the knowledge locked in our genes? And how can this knowledge become a real opportunity today?

The partnership will offer community hospitals and treatment centers around the world access to Intermountain’s best practices.

While evolving technology is paving the way, high drug costs, limited interoperability and physician skepticism need to be overcome.

Study takes a comprehensive and data-driven look at what happens to the brain during and after concussion.

From establishing centralized support and building a clinical trial management system to improving data integration with its Epic EMR, the academic medical center has worked extensively to put the pieces in place for genomics.

This podcast explores one key question: Who owns/profits from the data? This is a key question today for electronic medical records, and a question that has no straight answer.

MIT-Harvard research center upgrades GATK technology, widens availability to speed precision medicine advances.

HIMSS, AHIMA, AMIA all say the drastic cuts to ONC and other agencies will hamper patient safety and new cures, send innovation in a downward spiral and slow down work toward a learning health system.

In this podcast, we will review some of the ideas we shared in our previous podcasts on this series. We will also provide insights into what is new, what is driving the most current state of change and what we see as the next potential drivers.

Today’s IT infrastructures are not hearty enough to support the data needs of genomics and other emerging healthcare practices and capabilities,  HIMSS Analytics says.